BBH

VanEck Vectors Biotech ETF

Down$120.18
$-1.39
(-1.14%)
As of 12:00:00 AM EDT | 6/14/19  |  Market Closed

BBH Trading Data

Open

$123.26

Low Price

$120.13

High Price

$123.26

Previous Last Price

$121.57

Bid Size

$0 X 0

Ask Size

$0 X 0

BBH Portfolio Data

AUM

$358,294,400

Shares

2,947

PE Ratio

21.07

Price / Book Ratio

4

Expense Ratio

0.35

Net Asset Value

$121.60

Volume

Volume

12,300

Avg. Volume (YDT)

17,889

Dollar Volume

$691,097

Weekly Avg. Volume

10,460

Monthly Avg. Volume

23,420

Quarterly Avg. Volume

18,216

BBH Fund Description

The VanEck Vectors Biotech ETF seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index, which is intended to track the overall performance of companies involved in the development and production, marketing and sales of drugs based on genetic analysis and diagnostic equipment. Expenses for BBH are capped contractually at 0.35% until at least February 1, 2018. Cap excludes certain expenses, such as interest.

BBH Chart

BBH Summary

Fund Family

Van Eck Associates

Tracks This Index

VanEck Vectors Biotech ETF

Inception Date

2011-12-21

Asset Class

Equity

Asset Class Size

Biotech

BBH Classification

Region (General)

North America

Region (Specific)

US

Sector

Health Care

Equity Index

Leveraged Family

BBH Holdings

Top 10 Holdings

Amgen Inc (AMGN)
8.51%
Gilead Sciences Inc (GILD)
7.03%
Celgene Corp (CELG)
6.21%
Exact Sciences Corp (EXAS)
6.09%
Illumina Inc (ILMN)
6.07%
Iqvia Holdings Inc (IQV)
5.35%
Vertex Pharmaceuticals Inc (VRTX)
4.95%
Allergan Plc (AGN)
4.44%
Incyte Corp (INCY)
4.42%
Alexion Pharmaceuticals Inc (ALXN)
4.27%

Total BBH Holdings

Total Holdings: 27

Amgen Inc (AMGN)
8.51%
Gilead Sciences Inc (GILD)
7.03%
Celgene Corp (CELG)
6.21%
Exact Sciences Corp (EXAS)
6.09%
Illumina Inc (ILMN)
6.07%
Iqvia Holdings Inc (IQV)
5.35%
Vertex Pharmaceuticals Inc (VRTX)
4.95%
Allergan Plc (AGN)
4.44%
Incyte Corp (INCY)
4.42%
Alexion Pharmaceuticals Inc (ALXN)
4.27%
Biomarin Pharmaceutical Inc (BMRN)
4.21%
Qiagen Nv (QGEN)
3.99%
Sarepta Therapeutics Inc (SRPT)
3.9%
Beigene Ltd (BGNE)
3.88%
Regeneron Pharmaceuticals Inc (REGN)
3.8%
Biogen Inc (BIIB)
3.77%
Charles River Laboratories Internationa (CRL)
2.91%
Grifols Sa (GRFS)
2.8%
Neurocrine Biosciences Inc (NBIX)
2.48%
Alnylam Pharmaceuticals Inc (ALNY)
2.28%
Ionis Pharmaceuticals Inc (IONS)
1.98%
Nektar Therapeutics (NKTR)
1.97%
Seattle Genetics Inc (SGEN)
1.97%
United Therapeutics Corp (UTHR)
1.49%
Bluebird Bio Inc (BLUE)
1.12%
Market Vectors Biotech ETF (BBH)
0%
0%

BBH Technicals

Alpha

-8.34

Beta

1.25

Leverage

Long

Standard Deviation

6.01

BBH Dividends

Dividend Date

2018-12-20

Latest Dividend

5.551

Annual Dividend

5.55

Annual Dividend Rate

5.55

Annual Dividend Yield

4.56

BBH Performance

YTD Return

8.54%

1 Year Return

-1.48%

3 Year Return

18.39%

5 Year Return

26.81%

10 Year Return

287.43%

BBH Related Articles